Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records
Crossref DOI link: https://doi.org/10.1007/s13300-016-0177-8
Published Online: 2016-06-04
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kolaczynski, Wlodzimierz M.
Hankins, Matthew
Ong, Siew H.
Richter, Hartmut
Clemens, Andreas
Toussi, Massoud
Funding for this research was provided by:
Novartis Pharma AG (62010427)
Text and Data Mining valid from 2016-06-04
Article History
Received: 1 March 2016
First Online: 4 June 2016